Contemporary Insights into the Pharmacological Effects of Chalcones
DOI:
https://doi.org/10.29070/y70hmj80Keywords:
Chalcones, Anticancer, Anti-inflammatory, Antimalarial, Antidiabetic, Antiviral, Anti-AlzheimerAbstract
The chalcones constitute a group of α, β-unsaturated ketones that have attracted considerable attention within the field of medicinal chemistry because of the multiplicity of their pharmacological effects. These substances contain the structure of 1,3-diphenyl-2-propen-1-one, with α,β-unsaturated ketone moiety being responsible for their biological activity. The chalcones occur in nature as natural components of fruits, vegetables, tea, and soy foods; they are considered precursors of flavonoids and isoflavonoids. The derivatives of chalcones are known for exhibiting numerous pharmacological effects such as anticancer, anti-inflammatory, antimalarial, antidiabetic, antiviral, and anti-Alzheimer agents. Many natural chalcones and chalconoid preparations have also been used in traditional medicine.
Downloads
References
1. Ahmad, M. R., Khan, M. H. R., Sastry, V. G., Bano, N., Anwar, S., & Prasad, Y. R. (2012). A comparative study on synthesis of some novel α,β-unsaturated carbonyl derivatives and their antioxidant potential. European Journal of Chemistry, 3(2), 186–190. https://doi.org/10.5155/eurjchem.3.2.186-190.569
2. Andersen, O. M., & Markham, K. R. (Eds.). (2006). Flavonoids: Chemistry, biochemistry and applications. Taylor & Francis.
3. Penke, K., & Kamala, G. R. (2025). A review on chalcones as versatile scaffolds in drug discovery and development: Review article. Journal of Pharma Insights and Research, 3(4), 133–139. https://doi.org/10.69613/pbjfh046
4. Sahu, N. K., Balbhadra, S. S., Choudhary, J., & Kohli, D. V. (2012). Exploring pharmacological significance of chalcone scaffold: A review. Current Medicinal Chemistry, 19(2), 209–225. https://doi.org/10.2174/092986712803414056
5. Salehi, B., Quispe, C., Chamkhi, I., El Omari, N., Balahbib, A., Sharifi-Rad, J., Bouyahya, A., Akram, M., Iqbal, M., Docea, A. O., Caruntu, C., Leyva-Gómez, G., Dey, A., Martorell, M., Calina, D., López, V., & Les, F. (2021). Pharmacological properties of chalcones: A review of preclinical including molecular mechanisms and clinical evidence. Frontiers in Pharmacology, 11, Article 592654. https://doi.org/10.3389/fphar.2020.592654
6. Constantinescu, T., Lungu, C. N., Jazvinš’cak, M., & Jembrek, J. (2021). Anticancer activity of natural and synthetic chalcones. International Journal of Molecular Sciences, 22(20), Article 11306. https://doi.org/10.3390/ijms222011306
7. Hsieh, H.-K., Tsao, L.-T., Wang, J.-P., & Lin, C.-N. (2000). Synthesis and anti-inflammatory effect of chalcones. Journal of Pharmacy and Pharmacology, 52(2), 163–171. https://doi.org/10.1211/0022357001773869
8. Lagu, S. B., Yejella, R. P., Bhandare, R. R., & Shaik, A. B. (2020). Design, synthesis, and antibacterial and antifungal activities of novel trifluoromethyl and trifluoromethoxy substituted chalcone derivatives. Pharmaceuticals, 13, 375. https://doi.org/10.3390/ph13080375
9. Mahdi, I. S., Abdula, A. M., Jassim, A. M. N., & Baqi, Y. (2023). Design, synthesis, antimicrobial properties, and molecular docking of novel furan-derived chalcones and their 3,5-diaryl-∆2-pyrazoline derivatives. Antibiotics, 13(1), 21. https://doi.org/10.3390/antibiotics13010021
10. Haroun, M., Tratrat, C., Tsolaki, E., & Petrou, A. (2020). Thiazole-based chalcone derivatives as potential anti-inflammatory agents: Biological evaluation and molecular modelling. Current Topics in Medicinal Chemistry, 21(4), 285–296. https://doi.org/10.2174/1568026620666201207095556
11. Singh, M., Kaur, M., & Silakari, O. (2014). Flavones: An important scaffold for medicinal chemistry. European Journal of Medicinal Chemistry, 84, 206–239. https://doi.org/10.1016/j.ejmech.2014.07.013
12. Rajendran, G., Bhanu, D., Aruchamy, B., Ramani, P., Pandurangan, N., Bobba, K. N., Oh, E. J., Chung, H. Y., Gangadaran, P., & Ahn, B.-C. (2022). Chalcone: A promising bioactive scaffold in medicinal chemistry. Pharmaceuticals, 15(10), Article 1250. https://doi.org/10.3390/ph15101250
13. Bandgar, B. P., Gawande, S. S., Bodade, R. G., Totre, J. V., & Khobragade, C. N. (2010). Synthesis and biological evaluation of simple methoxylated chalcones as anticancer, anti-inflammatory and antioxidant agents. Bioorganic & Medicinal Chemistry, 18(4), 1364–1370. https://doi.org/10.1016/j.bmc.2010.01.008
14. Jain, U. K., Bhatia, R. K., Rao, A. R., Singh, R., Saxena, A. K., & Sehar, I. (2014). Design and development of halogenated chalcone derivatives as potential anticancer agents. Tropical Journal of Pharmaceutical Research, 13(1), 73–80.
15. Hatano, T., Kagawa, H., Yasuhara, T., & Okuda, T. (1988). Two new flavonoids and other constituents in licorice root: Their relative astringency and radical scavenging effects. Chemical and Pharmaceutical Bulletin, 36(6), 2090–2097. https://doi.org/10.1248/cpb.36.2090
16. Chen, J. J., Cheng, M. J., Shu, C. W., Sung, P. J., Lim, Y. P., Cheng, L. Y., Wang, L., & Chen, L. C. (2017). A new chalcone and antioxidant constituents of Glycyrrhiza glabra. Chemistry of Natural Compounds, 53(4), 632–634. https://doi.org/10.1007/s10600-017-2078-z
17. Rocha, S., Ribeiro, D., Fernandes, E., & Freitas, M. (2020). A systematic review on anti-diabetic properties of chalcones. Current Medicinal Chemistry, 27(14), 2257–2321. https://doi.org/10.2174/0929867325666181001112226
18. Mahapatra, D. K., Asati, V., & Bharti, S. K. (2015). Chalcones and their therapeutic targets for the management of diabetes: Structural and pharmacological perspectives. European Journal of Medicinal Chemistry, 92, 839–865. https://doi.org/10.1016/j.ejmech.2015.01.051
19. Rammohan, A., Reddy, J. S., & Sravya, G. (2020). Chalcone synthesis, properties and medicinal applications: A review. Environmental Chemistry Letters, 18(2), 433–458. https://doi.org/10.1007/s10311-019-00959-w
20. Rekha, M. J., Bettadaiah, B. K., Sindhu Kanya, T. C., & Govindaraju, K. (2020). A feasible method for isolation of pongamol from karanja (Pongamia pinnata) seed and its anti-inflammatory activity. Industrial Crops and Products, 154, 112720. https://doi.org/10.1016/j.indcrop.2020.112720
21. Toray Industries. (2013). Tissue transglutaminase inhibitors containing chalcone derivatives (1-thienyl-3-phenyl-2-propen-1-ones) and anti-Alzheimer agents containing them (Japan Patent No. JP2013180955).
22. Kang, L., Gao, X. H., Liu, H. R., Men, X., Wu, H. N., Cui, P. W., Oldfield, E., & Yan, J. Y. (2018). Structure–activity relationship investigation of coumarin–chalcone hybrids with diverse side-chains as acetyl cholinesterase and butyrylcholinesterase inhibitors. Molecular Diversity, 22(4), 893–906. https://doi.org/10.1007/s11030-018-9844-3
23. Kumar, R., Mohanakrishnan, D., Sharma, A., Kaushik, N. K., Kalia, K., Sinha, A. K., & Sahal, D. (2010). Reinvestigation of structure–activity relationship of methoxylated chalcones as antimalarials: Synthesis and evaluation of 2,4,5-trimethoxy substituted patterns as lead candidates derived from abundantly available natural α-asarone. European Journal of Medicinal Chemistry, 45(11), 5292–5301. https://doi.org/10.1016/j.ejmech.2010.08.050
24. Tadigoppula, N., Korthikunta, V., Gupta, S., Kancharla, P., Khaliq, T., Soni, A., Srivastava, R. K., Srivastava, K., Puri, S. K., Raju, K. S. R., & Mohammad, I. S. (2013). Synthesis and insight into the structure-activity relationships of chalcones as antimalarial agents. Journal of Medicinal Chemistry, 56(1), 31–45. https://doi.org/10.1021/jm300453p
25. Atukuri, D., Vijayalaxmi, S., Sanjeevamurthy, R., Vidya, L., Prasannakumar, R., & Raghavendra, M. M. (2020). Identification of quinoline-chalcones and heterocyclic chalcone-appended quinolines as broad-spectrum pharmacological agents. Bioorganic Chemistry, 105, 104419. https://doi.org/10.1016/j.bioorg.2020.104419
This work is licensed under a 